nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K2—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vascular cancer	0.0617	0.0617	CbGpPWpGaD
Trametinib—MAP2K1—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vascular cancer	0.0577	0.0577	CbGpPWpGaD
Trametinib—MAP2K2—Kit receptor signaling pathway—MITF—vascular cancer	0.0549	0.0549	CbGpPWpGaD
Trametinib—MAP2K1—RANKL/RANK Signaling Pathway—MITF—vascular cancer	0.0543	0.0543	CbGpPWpGaD
Trametinib—MAP2K1—Kit receptor signaling pathway—MITF—vascular cancer	0.0514	0.0514	CbGpPWpGaD
Trametinib—MAP2K2—mTOR signaling pathway—TSC2—vascular cancer	0.0234	0.0234	CbGpPWpGaD
Trametinib—MAP2K1—mTOR signaling pathway—TSC2—vascular cancer	0.0219	0.0219	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.0197	0.0197	CbGpPWpGaD
Trametinib—MAP2K2—IRS-mediated signalling—TSC2—vascular cancer	0.0191	0.0191	CbGpPWpGaD
Trametinib—MAP2K2—IRS-related events—TSC2—vascular cancer	0.0186	0.0186	CbGpPWpGaD
Trametinib—MAP2K2—IRS-related events triggered by IGF1R—TSC2—vascular cancer	0.0184	0.0184	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.0184	0.0184	CbGpPWpGaD
Trametinib—MAP2K2—Insulin receptor signalling cascade—TSC2—vascular cancer	0.0179	0.0179	CbGpPWpGaD
Trametinib—MAP2K2—IGF1R signaling cascade—TSC2—vascular cancer	0.0179	0.0179	CbGpPWpGaD
Trametinib—MAP2K1—IRS-mediated signalling—TSC2—vascular cancer	0.0179	0.0179	CbGpPWpGaD
Trametinib—MAP2K1—IRS-related events—TSC2—vascular cancer	0.0174	0.0174	CbGpPWpGaD
Trametinib—MAP2K1—IRS-related events triggered by IGF1R—TSC2—vascular cancer	0.0172	0.0172	CbGpPWpGaD
Trametinib—MAP2K1—Insulin receptor signalling cascade—TSC2—vascular cancer	0.0168	0.0168	CbGpPWpGaD
Trametinib—MAP2K1—IGF1R signaling cascade—TSC2—vascular cancer	0.0168	0.0168	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Insulin receptor—TSC2—vascular cancer	0.0149	0.0149	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—TSC2—vascular cancer	0.0139	0.0139	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—TSC2—vascular cancer	0.0127	0.0127	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—TSC2—vascular cancer	0.0125	0.0125	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.0122	0.0122	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—TSC2—vascular cancer	0.012	0.012	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—TSC2—vascular cancer	0.0119	0.0119	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—TSC2—vascular cancer	0.0117	0.0117	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—TSC2—vascular cancer	0.0115	0.0115	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—TSC2—vascular cancer	0.0115	0.0115	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.0114	0.0114	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—TSC2—vascular cancer	0.0114	0.0114	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—TSC2—vascular cancer	0.0113	0.0113	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—TSC2—vascular cancer	0.0113	0.0113	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—TSC2—vascular cancer	0.0112	0.0112	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—TSC2—vascular cancer	0.0108	0.0108	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—TSC2—vascular cancer	0.0107	0.0107	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—TSC2—vascular cancer	0.0107	0.0107	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—TSC2—vascular cancer	0.0106	0.0106	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.0106	0.0106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—TSC2—vascular cancer	0.0106	0.0106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—TSC2—vascular cancer	0.0106	0.0106	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—TSC2—vascular cancer	0.0106	0.0106	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—TSC2—vascular cancer	0.0105	0.0105	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.0104	0.0104	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—TSC2—vascular cancer	0.0104	0.0104	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00994	0.00994	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—TSC2—vascular cancer	0.00994	0.00994	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—TSC2—vascular cancer	0.00994	0.00994	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—TSC2—vascular cancer	0.00985	0.00985	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00976	0.00976	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—TSC2—vascular cancer	0.00972	0.00972	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00941	0.00941	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.0088	0.0088	CbGpPWpGaD
Trametinib—MAP2K2—Disease—WWTR1—vascular cancer	0.00758	0.00758	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—TSC2—vascular cancer	0.00723	0.00723	CbGpPWpGaD
Trametinib—MAP2K1—Disease—WWTR1—vascular cancer	0.0071	0.0071	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—TSC2—vascular cancer	0.00677	0.00677	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.00671	0.00671	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD34—vascular cancer	0.00555	0.00555	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—WWTR1—vascular cancer	0.00531	0.00531	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD34—vascular cancer	0.00519	0.00519	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—WWTR1—vascular cancer	0.00497	0.00497	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—TSC2—vascular cancer	0.00413	0.00413	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—TSC2—vascular cancer	0.00386	0.00386	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—WWTR1—vascular cancer	0.00299	0.00299	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TSC2—vascular cancer	0.0024	0.0024	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TSC2—vascular cancer	0.00225	0.00225	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TSC2—vascular cancer	0.00222	0.00222	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TSC2—vascular cancer	0.00208	0.00208	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HBA1—vascular cancer	0.00167	0.00167	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—WWTR1—vascular cancer	0.00161	0.00161	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TSC2—vascular cancer	0.00155	0.00155	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TSC2—vascular cancer	0.00145	0.00145	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HBA1—vascular cancer	0.000898	0.000898	CbGpPWpGaD
